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 Abstract  
 
 Patients with Ulcerative Colitis ( UC ) have prothrombotic tendencies, due it is 
suggested, to abnormalities in their coagulation profiles ( including alterations in protein 
C, S and factor V Leiden activity ). However it is unknown whether this necessitates 
additional perioperative anti-thrombotic prophylactic measures for major surgery.  We 
studied 79 patients with UC and 18 patients with Familial Adenomatous Polyposis ( FAP 
) who underwent major abdominal surgery examining their postoperative courses for both 
clinical and radiological evidence of venous thrombosis.  In patients with UC 180 
procedures were identified, 70 patients undergoing a subtotal colectomy, 51 an ileoanal 
pouch and 41 reversal of their ileostomy. The remaining procedures included 
adhesiolyses, repairs of fistulae, revision of stomas and excision of J-pouch. Eighteen 
patients with FAP underwent 35 operations, 13 undergoing restorative 
panproctocolectomy, 5 a subtotal colectomy with an ileorectal anastomosis, 4 a 
proctectomy and ileoanal pouch formation and 13 reversal of ileostomy none developing 
a venous thrombosis. Nine UC patients were investigated for postoperative venous 
thrombosis, but only three (3.8%) had their diagnosis proven radiologically. Three 
patients had a pulmonary embolus (PE), one after a subtotal colectomy, one after a J 
pouch formation and one following the resection of a pouch. Therefore the overall 
postoperative thrombosis rate, on an intention to treat basis, was 1.7% (3/180). From this 
we conclude that standard perioperative antithrombotic modalities are sufficient to 
maintain any potential increase in postoperative thrombotic risk at an acceptable level in 
patients with UC undergoing laparotomy. 
 
  
 
 
Introduction 
 
Patients with inflammatory bowel disease have an increased thrombotic tendency and 
have been shown to have a three fold increase in risk of developing a deep venous 
thrombosis ( DVT ) and PE1 compared to the average surgical population .The 
mechanism by which this occurs is unclear although there are many potential contributing 
factors including alterations in protein C, S, and factor V Leiden activity2 3. Furthermore, 
patients with exacerbations of their disease have a tendency to dehydration and may 
manifest increased plasma viscosity as a result of acute-phase protein release. 
 
As intra-abdominal surgery is a major risk factor for venous thrombosis, patients with UC 
may therefore be expected to have an increased risk of deep venous thrombosis and 
pulmonary embolism, especially in relation to emergency surgery. However, it is unclear 
whether this is actually so and whether these patients should receive anti-thrombotic 
precautions perioperatively greater than those routinely administered. We therefore 
retrospectively studied our experience of patients undergoing major abdominal surgery 
for UC including patients with FAP as a control group having similar age demographics 
and operative histories. Postoperative courses were examined for evidence of suspected 
and proven venous thromboses in order to suggest how these patients may be best 
managed perioperatively. 
 
 
 
 Methods 
 
Patients with UC and FAP undergoing abdominal procedures between 1991 and 2001 in 
a tertiary referral centre under a single consultant surgeon were identified using the 
Hospital Inpatient Enquiry ( HIPE ) system, our Inflammatory Bowel Disease database 
and theatre logbooks. Their postoperative courses were examined for clinical or 
radiological evidence of deep venous thrombosis or pulmonary embolism within one 
month of major abdominal or pelvic surgery; the data being retrieved using radiological 
databases and the patients' own medical records. Standard perioperative anti-thrombotic 
measures included: thromboembolic deterent ( TED ) stockings, early postoperative 
mobilisation and low molecular weight heparin ( Enoxaparin 1991-1999 20mg 
BD,Tinzaparin 199-2001 3,500 IU subcutaneously ) administration subcutaneously. 
 
Results 
 
79 patients with UC undergoing major abdominal surgery were identified, 53 of whom 
were male and 26 female. The mean age was 38.2 yrs ( range 2.5 – 72 ). In total, these 
patients underwent 180 operations: 70 had a subtotal colectomy, 51 had an ileoanal pouch 
formation and 41 had reversal of their defunctioning ileostomy performed. The remaining 
procedures included excision of rectum (n = 6), adhesiolysis for small bowel obstruction 
(n = 3), repair of fistula (n = 3), excision of J pouch (n = 4) and revision of stoma (n = 2).  
 
18 patients with FAP were identified, of whom 11 were male and 7 female. The mean age 
was 37.2 yrs ( range 16.5 – 79 ).These patients had 35 operations performed: 13 had a 
restorative panproctocolectomy. Five patients had a subtotal colectomy with an ileorectal 
anastomosis, 4 a proctectomy with ileoanal pouch formed and a further 13 reversal of 
their ileostomy. 
 
Postoperatively, nine UC patients were suspected clinically of having developed a 
postoperative venous thrombosis ( 2 DVT and 7 PE ) and were administered therapeutic 
doses of heparin. Only three ( 3.8% of total ) however were proven radiologically and 
therefore only these patients were anticoagulated with warfarin. One PE occurred after a 
subtotal colectomy ( 1.4% ), one after a J pouch formation ( 2% ) and one after a 
resection of a pouch for recurrent episodes of pelvic sepsis. Overall the postoperative 
venous thrombosis rate, on an intention to treat basis, was 1.7% ( 3 /180 ) .No patient 
with FAP was either suspected of or developed a venous thrombosis. 
 
Discussion 
Patients with UC have inherent prothrombotic tendencies, the aetiology of which remains 
to be elucidated. The significance of such venous thromboses is considerable as these 
patients tend to be of a young age and the associated morbidity is high3. Although it   has 
previously been shown that patients with inflammatory bowel disease have increased 
levels of anti-cardiolipin antibodies4, elevated titres were not necessarily associated with 
thromboembolic events during the study period. While further studies have failed to show 
an exact association between inflammatory bowel disease and hereditary prothrombotic 
conditions such as factor V Leiden and prothrombin gene mutations5, the overall increase 
in clotting tendency remains of considerable concern to clinicians managing these 
patients in the perioperative setting. 
The incidence of venous thrombosis despite prophylaxis after major abdominal surgery 
when both symptomatic and asymptomatic patients are screened using venography is 
6.3%6. In this study, however, we have demonstrated for the first time that patients’ with 
UC undergoing major intra-abdominal and intra-pelvic procedures, and receiving 
appropriate prophylaxis , do not in fact manifest an increased incidence of venous 
thrombosis in the first postoperative month. No patient with FAP developed a venous 
thrombosis and this may be a reflection of the different nature of their disease but also of 
the smaller numbers involved.  
 We thus conclude that standard prophylactic anti-thrombotic measures in patients with 
UC undergoing operation appear sufficient to deal with any potential increase in 
thrombotic risk and that additional measures are not necessary to ensure an acceptable 
incidence of postoperative venous thrombosis. These patients, therefore, need not be 
considered exceptionally”high-risk” in issues regarding their consent for intervention and 
perioperative care. 
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